These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2078973)

  • 21. [Reye's syndrome in an adult following therapy with salicylates in Still's disease].
    Tumiati B; Azzalito C; Veneziani M
    Medicina (Firenze); 1989; 9(1):64-5. PubMed ID: 2739536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute liver failure and encephalopathy (Reye's syndrome?) during salicylate therapy.
    Daum F; Zucker P; Cohen MI
    Acta Paediatr Scand; 1976 Nov; 65(6):747. PubMed ID: 998231
    [No Abstract]   [Full Text] [Related]  

  • 23. Salicylate promotes myeloperoxidase-initiated LDL oxidation: antagonization by its metabolite gentisic acid.
    Hermann M; Kapiotis S; Hofbauer R; Seelos C; Held I; Gmeiner B
    Free Radic Biol Med; 1999 May; 26(9-10):1253-60. PubMed ID: 10381197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of fatty acid beta oxidation by influenza B virus and salicylic acid in mice: implications for Reye's syndrome.
    Trauner DA; Horvath E; Davis LE
    Neurology; 1988 Feb; 38(2):239-41. PubMed ID: 3340286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simulated Reye's syndrome and salicylate therapy.
    Yoshida I; Yamashita F; Okada S; Horikoshi T
    Acta Paediatr Scand; 1984 Jul; 73(4):562-4. PubMed ID: 6464745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depression of oxidative metabolism of aspirin in mice via an interferon-associated mechanism in relation to Reye's syndrome.
    Dolphin CT; Caldwell J; Smith RL
    J Pharm Pharmacol; 1987 Mar; 39(3):228-30. PubMed ID: 2437280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salicylate poisoning: two-dimensional J-resolved NMR urinalysis.
    Maschke S; Azaroual N; Imbenotte M; Vermeersch G; Leclerc F; Lhermitte M
    NMR Biomed; 1995 Feb; 8(1):19-24. PubMed ID: 7547179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of true salicylate concentrations in serum from patients with Reye's syndrome.
    Kang ES; Todd TA; Capaci MT; Schwenzer K; Jabbour JT
    Clin Chem; 1983 Jun; 29(6):1012-4. PubMed ID: 6851086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reye's and Reye's-like syndromes.
    Pugliese A; Beltramo T; Torre D
    Cell Biochem Funct; 2008 Oct; 26(7):741-6. PubMed ID: 18711704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal case of Reye's syndrome associated with H3N2 influenza virus infection and salicylate intake in a 12-year-old patient.
    Ninove L; Daniel L; Gallou J; Cougard PA; Charpentier A; Viard L; Roquelaure B; Paquis-Flucklinger V; de Lamballerie X; Zandotti C; Charrel RN
    Clin Microbiol Infect; 2011 Jan; 17(1):95-7. PubMed ID: 20167009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carnitine metabolism and urinary organic acid excretion in Reye's syndrome and salicylate intoxication.
    Takayanagi M; Kakinuma H; Yamamoto S; Nakajima H
    Acta Paediatr Jpn; 1990 Aug; 32(4):406-9. PubMed ID: 2288223
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacterial oxidation of salicylate and related antirheumatic phenolic acids.
    ROOF BS; LANNON TJ; TURNER JC
    Proc Soc Exp Biol Med; 1953 Oct; 84(1):38-41. PubMed ID: 13120928
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic salicylism in a patient with juvenile rheumatoid arthritis.
    Everson GW; Krenzelok EP
    Clin Pharm; 1986 Apr; 5(4):334-41. PubMed ID: 3709082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered metabolic profiles of valproic acid in a patient with Reye's syndrome.
    Kuhara T; Inoue Y; Matsumoto M; Shinka T; Matsumoto I; Kitamura K; Fujii H; Sakura N
    Clin Chim Acta; 1985 Jan; 145(2):135-42. PubMed ID: 3918813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salicylic acid disposition in children with rheumatoid arthritis.
    Barzaghi N; Lamedica G; Gatti G; Cottafava F; Massocco D; Marchese N
    Fundam Clin Pharmacol; 1991; 5(4):285-90. PubMed ID: 1916612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salicylates, nitric oxide, malaria, and Reye's syndrome.
    Clark I; Whitten R; Molyneux M; Taylor T
    Lancet; 2001 Feb; 357(9256):625-7. PubMed ID: 11558501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-oxidation of [1-14C]palmitic acid by mouse astrocytes in primary culture: effects of agents implicated in the encephalopathy of Reye's syndrome.
    Murphy MG; Jollimore C; Crocker JF; Her H
    J Neurosci Res; 1992 Nov; 33(3):445-54. PubMed ID: 1469746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reye's syndrome: mitochondrial swelling and Ca2+ release induced by Reye's plasma, allantoin, and salicylate.
    Martens ME; Chang CH; Lee CP
    Arch Biochem Biophys; 1986 Feb; 244(2):773-86. PubMed ID: 3080954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reye's syndrome in the United States from 1981 through 1997.
    Belay ED; Bresee JS; Holman RC; Khan AS; Shahriari A; Schonberger LB
    N Engl J Med; 1999 May; 340(18):1377-82. PubMed ID: 10228187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum salicylate levels in a breast fed infant.
    Unsworth J; d'Assis-Fonseca A; Beswick DT; Blake DR
    Ann Rheum Dis; 1987 Aug; 46(8):638-9. PubMed ID: 3662653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.